½ÃÀ庸°í¼­
»óǰÄÚµå
1803991

¼¼°èÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® : ÄÄÆ÷³ÍÆ®º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° Àü¸Á°ú ¿¹Ãø(2025-2032³â)

Global Digital Health For Obesity Market Size, Share & Industry Analysis Report By Component (Services, Software, and Hardware), By End-use (Patients, Providers, Payers, and Other End-use.), By Regional Outlook and Forecast, 2025 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: KBV Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 358 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ Áß 23.3%ÀÇ CAGR·Î ½ÃÀå ¼ºÀåÇϸç, 2032³â±îÁö 2,937¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ÇÏÀ̶óÀÌÆ®:

  • ºÏ¹Ì ½ÃÀåÀº 2024³â ºñ¸¸ µðÁöÅÐ Çコ ½ÃÀåÀ» Àå¾ÇÇϰí 2024³â 36.98%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • ¹Ì±¹ÀÇ ºñ¸¸ µðÁöÅÐ Çコ ½ÃÀåÀº ºÏ¹Ì¿¡¼­ ¿ìÀ§¸¦ À¯ÁöÇϸç 2032³â±îÁö 275¾ï 8,000¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • ±¸¼º ¿ä¼Òº°·Î´Â ¼­ºñ½º ºÎ¹®ÀÌ 2024³â 37%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ¼¼°è ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµ Ãø¸é¿¡¼­ ȯÀÚ ºÎ¹®Àº 2032³â 37%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ¼¼°è ½ÃÀåÀ» Àå¾ÇÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºñ¸¸ µðÁöÅÐ Çコ ½ÃÀåÀº ºü¸£°Ô º¯È­Çϰí ÀÖÀ¸¸ç, °Ç°­ ÀÎ½Ä Áõ°¡, µðÁöÅÐ Çõ½Å, °øÁß º¸°ÇÀÇ ¿ä±¸°¡ À̸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº »óÈ£ ¿î¿ë °¡´ÉÇÑ Ç÷§Æû°ú Ãʱâ Ä®·Î¸® °è»ê ¾ÛºÎÅÍ AI Áö¿ø±îÁö ´Ù¾çÇÑ Ç÷§ÆûÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ÁÖ¸ñÇÒ ¸¸ÇÑ ÁøÀüÀ¸·Î´Â ¿¹Ãø ¹× °³ÀÎ ¸ÂÃãÇü Ä¡·á¸¦ À§ÇÑ AI¿Í MLÀÇ µµÀÔ, ÀεµÀÇ Ayushman Bharat Digital Mission°ú °°Àº Á¤ºÎ Áö¿ø µðÁöÅÐ ÇコÄɾî, ±×¸®°í WHO¿Í ITUÀÇ AI for health ±¸»ó°úÀÇ Çù·Â µîÀÌ ÀÖ½À´Ï´Ù. ¸¦ ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á, ¿þ¾î·¯ºí µ¥ÀÌÅÍ, Çൿ °úÇÐ, ¾à¹° Ä¡·áÀÇ °áÇÕÀ¸·Î Çõ½ÅÀûÀÎ ÅøÀº º¸Á¶ Åø¿¡¼­ ¸¸¼ºÁúȯ °ü¸®ÀÇ ÇÙ½É ¿ä¼Ò·Î ÁøÈ­Çϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀ» ÀçÆíÇÏ´Â ÁÖ¿ä µ¿Çâ¿¡´Â ½Ç½Ã°£ AI ±â¹Ý °¡»ó ÄÚĪÀÇ µîÀå, µðÁöÅÐ Ç÷§Æû°ú GLP-1 ±â¹Ý ¾à¹° Ä¡·áÀÇ À¶ÇÕ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àü ¼¼°è¿¡¼­ ºñ¸¸À²ÀÌ ³ô¾ÆÁö´Â °Íµµ Å« °ü½É»çÀÔ´Ï´Ù. World Obesity¿¡ µû¸£¸é ÇöÀç Àü ¼¼°è 10¾ï ¸í ÀÌ»óÀÌ ºñ¸¸À¸·Î °íÅë ¹Þ°í ÀÖÀ¸¸ç, ±× Áß ¼ºÀÎÀº ¾à 8¾ï 8,000¸¸ ¸í, 5¼¼¿¡¼­ 19¼¼ »çÀÌÀÇ ¾î¸°ÀÌ¿Í Ã»¼Ò³âÀº 1¾ï 5,900¸¸ ¸í¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. °á°úÀûÀ¸·Î, ÀÌ ºñ¸¸ Àü¿°º´Àº ºñ¸¸¿¡ ´ëÇÑ ½Å·ÚÇÒ ¼ö ÀÖ°í Çõ½ÅÀûÀ̸ç È®Àå °¡´ÉÇÑ µðÁöÅÐ °Ç°­ ¼Ö·ç¼ÇÀÇ ±ä±ÞÇÑ °ø±ÞÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ ½ÃÀå Àü·«Àº ÅëÇÕ µðÁöÅÐ Ç÷§Æû °³¹ß, Á¦¾à»ç¿ÍÀÇ Çù·Â, °èȹÀûÀÎ Àμö¸¦ ÅëÇÑ È®Àå, °øÁß º¸°Ç ¸ñÇ¥¿Í ÇÁ·ÎÁ§Æ® Á¶Á¤¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù.

KBV Cardinal matrix: ºñ¸¸Áõ µðÁöÅÐ Çコ ½ÃÀå °æÀï ºÐ¼®

KBV Cardinal matrix¿¡ ³ªÅ¸³­ ºÐ¼®¿¡ µû¸£¸é Fitbit, Inc.´Â ºñ¸¸ µðÁöÅÐ Çコ ½ÃÀåÀÇ ¼±±¸ÀÚÀÔ´Ï´Ù. 2022³â 9¿ù, Fitbit, Inc.´Â µ¥ÀÌÅͺ£À̽º ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) ¼Ö·ç¼ÇÀ» ¹ßÇ¥Çß½À´Ï´Ù. À̸¦ ÅëÇØ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ȯÀÚÀÇ °Ç°­ ÁöÇ¥¸¦ ¿ø°ÝÀ¸·Î ÃßÀûÇÒ ¼ö ÀÖ½À´Ï´Ù. RPM Ç÷§ÆûÀº üÁß, Ȱµ¿·®, ±âŸ °Ç°­ ÁöÇ¥¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇϰí ÀûÀýÇÑ ½Ã±â¿¡ °³ÀÔÇÔÀ¸·Î½á ºñ¸¸ °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. MyFitnessPal, Inc., Noom, Inc., Tempus AI, Inc. µîÀÇ ±â¾÷Àº ºñ¸¸ µðÁöÅÐ Çコ ½ÃÀåÀÇ ÁÖ¿ä Çõ½Å ±â¾÷ÀÔ´Ï´Ù.

COVID-19ÀÇ ¿µÇ⠺м®

COVID-19 ÆÒµ¥¹ÍÀº Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛ¿¡ Å« ºÎ´ãÀ» ÁÖ¾ú°í, µðÁöÅÐ Çコ ±â¼úÀÇ È°¿ëÀ» °¡¼ÓÈ­Çß½À´Ï´Ù. µðÁöÅÐ Çコ Ç÷§ÆûÀº COVID-19·Î ÀÎÇØ ½É°¢ÇÑ Áõ»óÀ» º¸ÀÏ °¡´É¼ºÀÌ ³ôÀº ºñ¸¸ ȯÀڵ鿡°Ô ÀÇ·á Áö¿øÀ» ¹ÞÀ» ¼ö ÀÖ´Â Áß¿äÇÑ ¼ö´ÜÀÌ µÇ¾ú½À´Ï´Ù. ¿ø°ÝÀÇ·á, ¸ð¹ÙÀÏ Çコ(¸ð¹ÙÀÏ Çコ) ¾Û, °¡»ó »ó´ãÀÌ º¸ÆíÈ­µÇ¸é¼­ ȯÀÚµéÀº Áý¿¡¼­ ¿µ¾ç»ç, ÇÇÆ®´Ï½º Àü¹®°¡, Çൿġ·á»ç¿Í »ó´ãÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

±¸¼º ¿ä¼Òº° Àü¸Á

±¸¼º ¿ä¼Ò¿¡ µû¶ó ½ÃÀåÀº ¼­ºñ½º, ¼ÒÇÁÆ®¿þ¾î, Çϵå¿þ¾î·Î ºÐ·ùµË´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ºÎ¹®Àº 2024³â ºñ¸¸ µðÁöÅÐ Çコ ½ÃÀå¿¡¼­ 34%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ºÎ¹®¿¡´Â ¸ð¹ÙÀÏ ¾Û, AI ±â¹Ý Ç÷§Æû, ±×¸®°í »ç¶÷µéÀÌ °Ç°­ ÁöÇ¥, ½Ä´Ü, ¿îµ¿, º¹¾à ¼øÀÀµµ¸¦ ÃßÀûÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ÅëÇÕ ½Ã½ºÅÛÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ºÎ¹®Àº ÀÚµ¿È­µÈ µ¥ÀÌÅͺ£À̽º ÀλçÀÌÆ®¸¦ °¡´ÉÇÏ°Ô Çϰí, »ç¶÷µéÀÌ ÀÚ½ÅÀÇ ÇൿÀ» ¸ð´ÏÅ͸µÇÏ°í º¯È­¸¦ À¯µµÇÏ´Â µ¥ ÀÖÀ¸¸ç, ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÃÖÁ¾ ¿ëµµº° Àü¸Á

ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó ½ÃÀåÀº ȯÀÚ, ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ, º¸Çè ÁöºÒÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ·Î ºÐ·ùµË´Ï´Ù. ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ ºÎ¹®Àº 2024³â ºñ¸¸ µðÁöÅÐ Çコ ½ÃÀå¿¡¼­ 26%ÀÇ ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. µðÁöÅÐ ÅøÀ» »ç¿ëÇÏ¿© ȯÀÚÀÇ ºñ¸¸À» Áø´Ü, ¸ð´ÏÅ͸µ, Ä¡·áÇÏ´Â ÀÇ·á Àü¹®°¡, Ŭ¸®´Ð, º´¿øÀº ¸ðµÎ ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ ºÎ¹®¿¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ÅøÀ» ÅëÇØ µ¥ÀÌÅÍ¿¡ ±â¹ÝÇÑ ÀÇ»ç°áÁ¤, ¿ø°Ý ¸ð´ÏÅ͸µ, ±×¸®°í ÅëÇÕµÈ Äɾî Á¦°øÀÌ °¡´ÉÇØÁý´Ï´Ù.

Áö¿ª Àü¸Á

Áö¿ªº°·Î´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, LAMEA·Î ³ª´¹´Ï´Ù. ºÏ¹Ì ºÎ¹®Àº 2024³â ºñ¸¸ µðÁöÅÐ Çコ ½ÃÀå¿¡¼­ 37%ÀÇ ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ºÏ¹Ì¿Í À¯·´ÀÇ ºñ¸¸ µðÁöÅÐ Çコ ½ÃÀåÀº °íµµÈ­µÈ ÇコÄÉ¾î ½Ã½ºÅÛ, µðÁöÅÐ Çコ ÅøÀÇ Á¶±â »ç¿ë, °úüÁßÀ¸·Î ÀÎÇÑ °Ç°­ À§Çè¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Å« ÆøÀÇ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. °­·ÂÇÑ »óȯ Á¤Ã¥°ú AI ±â¹Ý ºñ¸¸ °ü¸® Ç÷§ÆûÀÇ »ç¿ëÀº ºÏ¹Ì, ƯÈ÷ ¹Ì±¹¿¡¼­ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ Ä¡·áÁ¦´Â À¯·´, ƯÈ÷ µ¶ÀÏ, ¿µ±¹, ÇÁ¶û½º¿¡¼­ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ´Â ¸¸¼ºÁúȯ °ü¸®¿¡ ÃÊÁ¡À» ¸ÂÃá Áö¿ø¹ý°ú ±¹°¡ º¸°Ç ÇÁ·Î±×·¥¿¡ ÀÇÇÑ °ÍÀÔ´Ï´Ù.

ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â ½ÃÀåÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ½º¸¶Æ®ÆùÀÇ º¸±Þ, ¼Òµæ Áõ°¡, ±×¸®°í µµ½Ã Áö¿ª¿¡¼­ÀÇ ºñ¸¸ Áõ°¡°¡ ±× ¿øÀÎÀÔ´Ï´Ù. Áß±¹, Àεµ, ÀϺ» ¸ðµÎ »ýȰ½À°üº´ °ü·Ã ÁúȯÀ» ´ë»óÀ¸·Î ÇÑ ¸ð¹ÙÀÏ Çコ ±â¼ú°ú ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. LAMEA(¿µ±¹ ÀÇ»çÇùȸ)µµ µðÁöÅÐ ÀÎÇÁ¶óÀÇ Á¤ºñ¿Í Á¤ºÎ ÁÖµµÀÇ °è¸ùȰµ¿ÀÇ ÁøÀü¿¡ µû¶ó ÀÌ·¯ÇÑ ±â¼úµéÀ» Á¡Â÷ µµÀÔÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÷´Ü ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼º Á¦ÇÑ, ±ÔÁ¦ ȯ°æÀÇ Â÷ÀÌ µî ¿©ÀüÈ÷ °úÁ¦°¡ ³²¾ÆÀÖ½À´Ï´Ù.

½ÃÀå °æÀï°ú Ư¼º

½ÅÈï µðÁöÅÐ ÇコÄÉ¾î ¾÷üµéÀº AI¸¦ Ȱ¿ëÇÑ ´ë»ç ÇÁ·ÎÆÄÀϸµ, ¿ø°ÝÀÇ·á Á¦°ø, ¿þ¾î·¯ºí ±â±â¿ÍÀÇ ¿¬µ¿, °³ÀÎÈ­µÈ Çൿ ÇÁ·Î±×·¥ µî Æ´»õ ½ÃÀå¿¡¼­ÀÇ Çõ½ÅÀ» ÅëÇØ Ä¡¿­ÇÑ °æÀïÀ» ¹úÀ̰í ÀÖ½À´Ï´Ù. ½ºÅ¸Æ®¾÷°ú Áö¿ª Ç÷§ÆûÀº »ç¿ëÀÚ Âü¿©, »óÈ£¿î¿ë¼º, ¸ÂÃãÇü ¼Ö·ç¼Ç¿¡ ÁýÁßÇÔÀ¸·Î½á ±â¼ú°ú ÀÓ»ó °ËÁõÀ» ÅëÇØ ºü¸£°Ô ÁøÈ­Çϰí ÀÖÀ¸¸ç, °íµµ·Î ¼¼ºÐÈ­µÈ ½ÃÀå¿¡¼­ Ÿ»ç¿ÍÀÇ Â÷º°È­¸¦ ²ÒÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§ ¹× ºÐ¼® ¹æ¹ý

  • ½ÃÀåÀÇ Á¤ÀÇ
  • ¸ñÀû
  • ½ÃÀå ¹üÀ§
  • ¼¼ºÐÈ­
  • ºÐ¼® ¹æ¹ý

Á¦2Àå ½ÃÀå °³°ü

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

Á¦3Àå ½ÃÀå °³¿ä

  • ¼­·Ð
    • °³¿ä
      • ½ÃÀå ±¸¼º°ú ½Ã³ª¸®¿À
  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦

Á¦4Àå ½ÃÀå µ¿Çâ : ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå

Á¦5Àå °æÀï ±¸µµ : ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå

Á¦6Àå ÁÖ¿ä °í°´ ±âÁØ : ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå

Á¦7Àå Á¦Ç°¼ö¸íÁÖ±â(PLC) : ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå

Á¦8Àå ½ÃÀå ÅëÇÕ : ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå

Á¦9Àå °æÀï ºÐ¼® : ¼¼°è ½ÃÀå

  • KBV Cardinal Matrix
  • ÃÖ±Ù ¾÷°è ÀüüÀÇ Àü·«Àû °³¹ß
    • »ç¾÷ Á¦ÈÞ¡¤Çù·Â, °è¾à
    • Á¦Ç° ¹ß¸Å¡¤È®´ë
    • ±â¾÷ÀμöÇÕº´(M&A)
  • ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
  • ÁÖ¿ä ¼º°ø Àü·«
    • ÁÖ¿ä Àü·«
    • ÁÖ¿ä Àü·«Àû ¿òÁ÷ÀÓ
  • Porter's Five Forces ºÐ¼®

Á¦10Àå ¹ë·ùüÀÎ ºÐ¼® : ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå

  • µ¥ÀÌÅÍ ¼öÁý°ú ÅëÇÕ
  • ÀÓ»ó Æò°¡¿Í ¸®½ºÅ© Ãþº°È­
  • °³ÀÔ ¼³°è(Çൿ, ¿µ¾ç, ÀÇ·á)
  • Ç÷§Æû °³¹ß°ú UX/UI
  • ÆÄÆ®³Ê ¿¡ÄڽýºÅÛ°ú µô¸®¹ö¸® ÅëÇÕ
  • ȯÀÚ °ü¿©, ¸ð´ÏÅ͸µ, Áö¿ø
  • ÀÓ»ó °ËÁõ°ú ±ÔÁ¦ Áؼö
  • ¼º°ú ÃøÁ¤°ú »óȯ ÅëÇÕ

Á¦11Àå ¼¼°èÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ¼¼°èÀÇ ¼­ºñ½º ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ Çϵå¿þ¾î ½ÃÀå : Áö¿ªº°

Á¦12Àå ¼¼°èÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ¼¼°èÀÇ È¯ÀÚ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ÀÇ·á Á¦°øÀÚ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ º¸Çè ÁöºÒÀÚ ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ±âŸ ÃÖÁ¾ ¿ëµµ ½ÃÀå : Áö¿ªº°

Á¦13Àå ¼¼°èÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
    • ºÏ¹ÌÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå : ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
      • ±âŸ ºÏ¹Ì
  • À¯·´
  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
    • À¯·´ÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå : ±¹°¡º°
      • µ¶ÀÏ
      • ¿µ±¹
      • ÇÁ¶û½º
      • ·¯½Ã¾Æ
      • ½ºÆäÀÎ
      • ÀÌÅ»¸®¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå : ±¹°¡º°
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • Çѱ¹
      • ½Ì°¡Æ÷¸£
      • ¸»·¹À̽þÆ
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(LAMEA)
  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
    • ¶óƾ¾Æ¸Þ¸®Ä«¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå : ±¹°¡º°
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ¾Æ¶ø¿¡¹Ì¸®Æ®
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
      • ³ªÀÌÁö¸®¾Æ
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦14Àå ±â¾÷ °³¿ä

  • Noom, Inc
  • WW International Inc
  • MyFitnessPal, Inc
  • Teladoc Health, Inc
  • Fitbit, Inc(Google LLC)
  • HealthifyMe Wellness Private Limited
  • PlateJoy LLC
  • Tempus AI, Inc
  • Welldoc, Inc
  • Sidekick Health ehf

Á¦15Àå ºñ¸¸ ½ÃÀå¿¡¼­ µðÁöÅÐ ÇコÀÇ ¼º°ø Çʼö Á¶°Ç

KSA 25.09.11

The Global Digital Health For Obesity Market size is expected to reach USD 293.71 billion by 2032, rising at a market growth of 23.3% CAGR during the forecast period.

Key Highlights:

  • The North America market dominated the Global Digital Health For Obesity Market in 2024, accounting for a 36.98% revenue share in 2024.
  • The US Digital Health For Obesity market is expected to continue its dominance in North America region thereby reaching a market size of USD 27.58 billion by 2032.
  • Among the various component segment, the services segment dominated the global market contributing a revenue share of 37% in 2024.
  • In terms of the End Use, the patients segment is projected to dominate the global market with the projected revenue share of 37% in 2032.

The digital health for obesity market is changing swiftly, it is driven by the rising health awareness, digital innovations, and public health imperatives. Market supports a bunch of platforms such as interoperable platforms, and early calorie-counting apps to AI-enabled. Notable advancements are adoption of AI and ML for predictive and tailored-care, state-backed digital healthcare such as Ayushman Bharat Digital Mission in India and collaboration between WHO and ITU's AI-for-health initiatives. The combination telemedicine, wearable data, behavioural science, and pharmacotherapy has increased innovative tools from supplemental tools to core elements of chronic disease management.

Main trends reshaping the market encompass emergence of AI-powered virtual coaching for real-time, mix of digital platforms with GLP-1-based pharmacological treatment. Also, the rising obesity rates worldwide is a big concern. According to World Obesity, more than one billion people in the world are now living with obesity, nearly 880 million adults and 159 million children and adolescents aged 5-19 years. As a result, this obesity epidemic underscores an urgent supply of the reliable, innovative and scalable digital health solutions for obesity. Market strategies adopted by the key companies are rising focus on developing unified digital platforms, working with pharmaceutical companies, expanding through calculated acquisitions, and coordinating projects with the goals of public health.

The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, In January, 2025, Tempus AI, Inc. unveiled new generative AI tools aimed at improving clinical care and research. These AI solutions assist healthcare providers with faster data analysis and personalized insights. Such tools could also enhance obesity management by enabling more precise care recommendations through digital health platforms. In October, 2024, Noom, Inc. unveiled two enterprise solutions to help employers manage and reduce GLP-1 medication expenses. These offerings combine digital health coaching, education, and medication oversight to deliver cost-effective obesity management strategies, enhancing support for employees using GLP-1 drugs as part of their weight loss journey.

KBV Cardinal Matrix - Digital Health For Obesity Market Competition Analysis

Based on the Analysis presented in the KBV Cardinal matrix; Fitbit, Inc. is the forerunner in the Digital Health For Obesity Market. In September, 2022, Fitbit, Inc. unveiled a data-driven Remote Patient Monitoring (RPM) solution, enabling healthcare providers to track patients' health metrics remotely. This RPM platform plays a vital role in obesity management by continuously monitoring weight, activity, and other health indicators for timely interventions. Companies such as MyFitnessPal, Inc., Noom, Inc., and Tempus AI, Inc. are some of the key innovators in Digital Health For Obesity Market.

COVID 19 Impact Analysis

The COVID-19 pandemic put a lot of stress on healthcare systems around the world, which sped up the use of digital health technologies. Digital health platforms became an important way for people with obesity, who were more likely to have serious COVID-19 problems, to get medical help. Telemedicine, mobile health (mHealth) apps, and virtual consultations became popular, giving patients access to nutritionists, fitness experts, and behavioral therapists from the comfort of their own homes.

Component Outlook

Based on Component, the market is segmented into Services, Software, and Hardware. The software segment procured 34% revenue share in the digital health for obesity market in 2024. The software part includes mobile apps, AI-powered platforms, and integrated systems that help people keep track of their health metrics, diet, exercise, and medication adherence. This part is very important for making automated, data-driven insights possible and encouraging people to monitor and change their behavior.

End-use Outlook

Based on End-use, the market is segmented into Patients, Providers, Payers, and Other End-use. The providers segment recorded 26% revenue share in the digital health for obesity market in 2024. Healthcare professionals, clinics, and hospitals that use digital tools to diagnose, monitor, and treat obesity in patients are all part of the providers segment. These tools let you make decisions based on data, keep an eye on things from a distance, and provide care in a way that works together.

Regional Outlook

Region-wise, the market is segmented into North America, Europe, Asia Pacific and LAMEA. The North America segment recorded 37% revenue share in the digital health for obesity market in 2024. The digital health for obesity market in North America and Europe is on the substantially growth track because of advanced healthcare systems, early use of digital health tools and more people knowing about the health risks that come with being overweight. Strong reimbursement policies and the use of AI-driven obesity management platforms are speeding up market growth in North America, especially in the U.S. Digital therapeutics are becoming more popular in Europe, especially in Germany, the UK, and France. This is because of supportive laws and national health programs that focus on managing chronic diseases.

On the other hand, the Asia-Pacific region is becoming the fastest-growing market. This is because more people are getting smartphones, more people are making more money, and more people are becoming obese in cities. China, India, and Japan are all putting money into mobile health technologies and remote patient monitoring systems that are made for diseases that are linked to lifestyle. LAMEA are also slowly adopting it, due to better digital infrastructure and government-led awareness programs. However, there are still problems, such as limited access to advanced technology and different regulatory environments.

Market Competition and Attributes

Emerging digital health providers are fiercely competing through niche innovation, such as AI driven metabolic profiling, telehealth delivery, wearable integration, and personalized behavioral programs. Startups and regional platforms focus on user engagement, interoperability, and tailored solutions to stand out in a rapidly evolving, highly fragmented market driven by technology and clinical validation.

Recent Strategies Deployed in the Market

  • Jun-2025: Welldoc, Inc. announced the partnership with Eli Lilly to power the newly launched Lilly Health app, targeting users of incretin therapies like Zepbound and Mounjaro. This AI-enabled digital health platform offers medication logging, reminders, device integration, nutrition/exercise guidance, and health tracking-supporting personalized weight and cardiometabolic care for obesity and related conditions.
  • Apr-2025: Sidekick Health ehf teamed up with Ypsomed to integrate Ypsomed's SmartPilot-equipped autoinjectors with Sidekick's chronic-condition app, forming an obesity-focused digital health platform. It combines real-time GLP-1 injection tracking, behavioral coaching, educational content, reminders, and pharma-level data sharing to boost adherence and weight-loss success.
  • Mar-2025: Noom, Inc. announced the partnership with Collective Health to provide a comprehensive weight management solution, integrating Noom's behavioral programs with GLP-1 medication support. The partnership aims to help employers offer sustainable obesity management solutions for their workforce, addressing rising obesity-related healthcare costs through the use of digital health tools and coordinated care.
  • Mar-2025: Tempus AI, Inc. announced the acquisition of Deep 6 AI, a company that uses AI to identify clinical trial participants. This strengthens Tempus' capabilities in real-world evidence and patient recruitment, potentially improving digital health research for various conditions, including obesity, where targeted trials and personalized interventions are critical.
  • Feb-2025: MyFitnessPal, Inc. announced the acquisition of meal planning startup Intent to enhance its personalized nutrition offerings. This move aims to support users, particularly those managing obesity or metabolic health, by providing tailored meal recommendations integrated with MyFitnessPal's platform, thereby contributing to digital health solutions that target weight management and obesity.

List of Key Companies Profiled

  • Noom, Inc.
  • WW International Inc.
  • MyFitnessPal, Inc.
  • Teladoc Health, Inc.
  • Fitbit, Inc. (Google LLC)
  • HealthifyMe Wellness Private Limited
  • PlateJoy LLC
  • Tempus AI, Inc.
  • Welldoc, Inc.
  • Sidekick Health ehf

Global Digital Health For Obesity Market Report Segmentation

By Component

  • Services
  • Software
  • Hardware

By End-use

  • Patients
  • Providers
  • Payers
  • Other End-use

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Digital Health For Obesity Market, by Component
    • 1.4.2 Global Digital Health For Obesity Market, by End-use
    • 1.4.3 Global Digital Health For Obesity Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges

Chapter 4. Market Trends - Digital Health For Obesity Market

Chapter 5. State of Competition - Digital Health For Obesity Market

Chapter 6. Key Costumer Criteria - Digital Health For Obesity Market

Chapter 7. Product Life Cycle (PLC) - Digital Health For Obesity Market

Chapter 8. Market Consolidation Analysis - Digital Health For Obesity Market

Chapter 9. Competition Analysis - Global

  • 9.1 KBV Cardinal Matrix
  • 9.2 Recent Industry Wide Strategic Developments
    • 9.2.1 Partnerships, Collaborations and Agreements
    • 9.2.2 Product Launches and Product Expansions
    • 9.2.3 Acquisition and Mergers
  • 9.3 Top Winning Strategies
    • 9.3.1 Key Leading Strategies: Percentage Distribution (2021-2025)
    • 9.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2021, Aug - 2025, Jan) Leading Players
  • 9.4 Porter Five Forces Analysis

Chapter 10. Value Chain Analysis of Digital Health For Obesity Market

  • 10.1 Data Acquisition & Integration
  • 10.2 Clinical Assessment & Risk Stratification
  • 10.3 Intervention Design (Behavioral, Nutritional, Medical)
  • 10.4 Platform Development & UX/UI
  • 10.5 Partner Ecosystem & Delivery Integration
  • 10.6 Patient Engagement, Monitoring & Support
  • 10.7 Clinical Validation & Regulatory Compliance
  • 10.8 Outcomes Measurement & Reimbursement Integration

Chapter 11. Global Digital Health For Obesity Market by Component

  • 11.1 Global Services Market by Region
  • 11.2 Global Software Market by Region
  • 11.3 Global Hardware Market by Region

Chapter 12. Global Digital Health For Obesity Market by End-use

  • 12.1 Global Patients Market by Region
  • 12.2 Global Providers Market by Region
  • 12.3 Global Payers Market by Region
  • 12.4 Global Other End-use Market by Region

Chapter 13. Global Digital Health For Obesity Market by Region

  • 13.1 North America Digital Health For Obesity Market
  • 13.2 Key Factors Impacting the Market
    • 13.2.1 Market Drivers
    • 13.2.2 Market Restraints
    • 13.2.3 Market Opportunities
    • 13.2.4 Market Challenges
    • 13.2.5 North America Digital Health For Obesity Market by Component
      • 13.2.5.1 North America Services Market by Country
      • 13.2.5.2 North America Software Market by Country
      • 13.2.5.3 North America Hardware Market by Country
    • 13.2.6 North America Digital Health For Obesity Market by End-use
      • 13.2.6.1 North America Patients Market by Country
      • 13.2.6.2 North America Providers Market by Country
      • 13.2.6.3 North America Payers Market by Country
      • 13.2.6.4 North America Other End-use Market by Country
    • 13.2.7 North America Digital Health For Obesity Market by Country
      • 13.2.7.1 US Digital Health For Obesity Market
        • 13.2.7.1.1 US Digital Health For Obesity Market by Component
        • 13.2.7.1.2 US Digital Health For Obesity Market by End-use
      • 13.2.7.2 Canada Digital Health For Obesity Market
        • 13.2.7.2.1 Canada Digital Health For Obesity Market by Component
        • 13.2.7.2.2 Canada Digital Health For Obesity Market by End-use
      • 13.2.7.3 Mexico Digital Health For Obesity Market
        • 13.2.7.3.1 Mexico Digital Health For Obesity Market by Component
        • 13.2.7.3.2 Mexico Digital Health For Obesity Market by End-use
      • 13.2.7.4 Rest of North America Digital Health For Obesity Market
        • 13.2.7.4.1 Rest of North America Digital Health For Obesity Market by Component
        • 13.2.7.4.2 Rest of North America Digital Health For Obesity Market by End-use
  • 13.3 Europe Digital Health For Obesity Market
  • 13.4 Key Factors Impacting the Market
    • 13.4.1 Market Drivers
    • 13.4.2 Market Restraints
    • 13.4.3 Market Opportunities
    • 13.4.4 Market Challenges
    • 13.4.5 Europe Digital Health For Obesity Market by Component
      • 13.4.5.1 Europe Services Market by Country
      • 13.4.5.2 Europe Software Market by Country
      • 13.4.5.3 Europe Hardware Market by Country
    • 13.4.6 Europe Digital Health For Obesity Market by End-use
      • 13.4.6.1 Europe Patients Market by Country
      • 13.4.6.2 Europe Providers Market by Country
      • 13.4.6.3 Europe Payers Market by Country
      • 13.4.6.4 Europe Other End-use Market by Country
    • 13.4.7 Europe Digital Health For Obesity Market by Country
      • 13.4.7.1 Germany Digital Health For Obesity Market
        • 13.4.7.1.1 Germany Digital Health For Obesity Market by Component
        • 13.4.7.1.2 Germany Digital Health For Obesity Market by End-use
      • 13.4.7.2 UK Digital Health For Obesity Market
        • 13.4.7.2.1 UK Digital Health For Obesity Market by Component
        • 13.4.7.2.2 UK Digital Health For Obesity Market by End-use
      • 13.4.7.3 France Digital Health For Obesity Market
        • 13.4.7.3.1 France Digital Health For Obesity Market by Component
        • 13.4.7.3.2 France Digital Health For Obesity Market by End-use
      • 13.4.7.4 Russia Digital Health For Obesity Market
        • 13.4.7.4.1 Russia Digital Health For Obesity Market by Component
        • 13.4.7.4.2 Russia Digital Health For Obesity Market by End-use
      • 13.4.7.5 Spain Digital Health For Obesity Market
        • 13.4.7.5.1 Spain Digital Health For Obesity Market by Component
        • 13.4.7.5.2 Spain Digital Health For Obesity Market by End-use
      • 13.4.7.6 Italy Digital Health For Obesity Market
        • 13.4.7.6.1 Italy Digital Health For Obesity Market by Component
        • 13.4.7.6.2 Italy Digital Health For Obesity Market by End-use
      • 13.4.7.7 Rest of Europe Digital Health For Obesity Market
        • 13.4.7.7.1 Rest of Europe Digital Health For Obesity Market by Component
        • 13.4.7.7.2 Rest of Europe Digital Health For Obesity Market by End-use
  • 13.5 Asia Pacific Digital Health For Obesity Market
  • 13.6 Key Factors Impacting the Market
    • 13.6.1 Market Drivers
    • 13.6.2 Market Restraints
    • 13.6.3 Market Opportunities
    • 13.6.4 Market Challenges
    • 13.6.5 Asia Pacific Digital Health For Obesity Market by Component
      • 13.6.5.1 Asia Pacific Services Market by Country
      • 13.6.5.2 Asia Pacific Software Market by Country
      • 13.6.5.3 Asia Pacific Hardware Market by Country
    • 13.6.6 Asia Pacific Digital Health For Obesity Market by End-use
      • 13.6.6.1 Asia Pacific Patients Market by Country
      • 13.6.6.2 Asia Pacific Providers Market by Country
      • 13.6.6.3 Asia Pacific Payers Market by Country
      • 13.6.6.4 Asia Pacific Other End-use Market by Country
    • 13.6.7 Asia Pacific Digital Health For Obesity Market by Country
      • 13.6.7.1 China Digital Health For Obesity Market
        • 13.6.7.1.1 China Digital Health For Obesity Market by Component
        • 13.6.7.1.2 China Digital Health For Obesity Market by End-use
      • 13.6.7.2 Japan Digital Health For Obesity Market
        • 13.6.7.2.1 Japan Digital Health For Obesity Market by Component
        • 13.6.7.2.2 Japan Digital Health For Obesity Market by End-use
      • 13.6.7.3 India Digital Health For Obesity Market
        • 13.6.7.3.1 India Digital Health For Obesity Market by Component
        • 13.6.7.3.2 India Digital Health For Obesity Market by End-use
      • 13.6.7.4 South Korea Digital Health For Obesity Market
        • 13.6.7.4.1 South Korea Digital Health For Obesity Market by Component
        • 13.6.7.4.2 South Korea Digital Health For Obesity Market by End-use
      • 13.6.7.5 Singapore Digital Health For Obesity Market
        • 13.6.7.5.1 Singapore Digital Health For Obesity Market by Component
        • 13.6.7.5.2 Singapore Digital Health For Obesity Market by End-use
      • 13.6.7.6 Malaysia Digital Health For Obesity Market
        • 13.6.7.6.1 Malaysia Digital Health For Obesity Market by Component
        • 13.6.7.6.2 Malaysia Digital Health For Obesity Market by End-use
      • 13.6.7.7 Rest of Asia Pacific Digital Health For Obesity Market
        • 13.6.7.7.1 Rest of Asia Pacific Digital Health For Obesity Market by Component
        • 13.6.7.7.2 Rest of Asia Pacific Digital Health For Obesity Market by End-use
  • 13.7 LAMEA Digital Health For Obesity Market
  • 13.8 Key Factors Impacting the Market
    • 13.8.1 Market Drivers
    • 13.8.2 Market Restraints
    • 13.8.3 Market Opportunities
    • 13.8.4 Market Challenges
    • 13.8.5 LAMEA Digital Health For Obesity Market by Component
      • 13.8.5.1 LAMEA Services Market by Country
      • 13.8.5.2 LAMEA Software Market by Country
      • 13.8.5.3 LAMEA Hardware Market by Country
    • 13.8.6 LAMEA Digital Health For Obesity Market by End-use
      • 13.8.6.1 LAMEA Patients Market by Country
      • 13.8.6.2 LAMEA Providers Market by Country
      • 13.8.6.3 LAMEA Payers Market by Country
      • 13.8.6.4 LAMEA Other End-use Market by Country
    • 13.8.7 LAMEA Digital Health For Obesity Market by Country
      • 13.8.7.1 Brazil Digital Health For Obesity Market
        • 13.8.7.1.1 Brazil Digital Health For Obesity Market by Component
        • 13.8.7.1.2 Brazil Digital Health For Obesity Market by End-use
      • 13.8.7.2 Argentina Digital Health For Obesity Market
        • 13.8.7.2.1 Argentina Digital Health For Obesity Market by Component
        • 13.8.7.2.2 Argentina Digital Health For Obesity Market by End-use
      • 13.8.7.3 UAE Digital Health For Obesity Market
        • 13.8.7.3.1 UAE Digital Health For Obesity Market by Component
        • 13.8.7.3.2 UAE Digital Health For Obesity Market by End-use
      • 13.8.7.4 Saudi Arabia Digital Health For Obesity Market
        • 13.8.7.4.1 Saudi Arabia Digital Health For Obesity Market by Component
        • 13.8.7.4.2 Saudi Arabia Digital Health For Obesity Market by End-use
      • 13.8.7.5 South Africa Digital Health For Obesity Market
        • 13.8.7.5.1 South Africa Digital Health For Obesity Market by Component
        • 13.8.7.5.2 South Africa Digital Health For Obesity Market by End-use
      • 13.8.7.6 Nigeria Digital Health For Obesity Market
        • 13.8.7.6.1 Nigeria Digital Health For Obesity Market by Component
        • 13.8.7.6.2 Nigeria Digital Health For Obesity Market by End-use
      • 13.8.7.7 Rest of LAMEA Digital Health For Obesity Market
        • 13.8.7.7.1 Rest of LAMEA Digital Health For Obesity Market by Component
        • 13.8.7.7.2 Rest of LAMEA Digital Health For Obesity Market by End-use

Chapter 14. Company Profiles

  • 14.1 Noom, Inc.
    • 14.1.1 Company Overview
    • 14.1.2 Recent strategies and developments:
      • 14.1.2.1 Partnerships, Collaborations, and Agreements:
      • 14.1.2.2 Product Launches and Product Expansions:
  • 14.2 WW International Inc.
    • 14.2.1 Company Overview
    • 14.2.2 Financial Analysis
    • 14.2.3 Regional Analysis
    • 14.2.4 Recent strategies and developments:
      • 14.2.4.1 Partnerships, Collaborations, and Agreements:
      • 14.2.4.2 Acquisition and Mergers:
  • 14.3 MyFitnessPal, Inc.
    • 14.3.1 Company Overview
    • 14.3.2 Recent strategies and developments:
      • 14.3.2.1 Partnerships, Collaborations, and Agreements:
      • 14.3.2.2 Product Launches and Product Expansions:
      • 14.3.2.3 Acquisition and Mergers:
  • 14.4 Teladoc Health, Inc.
    • 14.4.1 Company Overview
    • 14.4.2 Financial Analysis
    • 14.4.3 Segmental and Regional Analysis
    • 14.4.4 Research & Development Expenses
    • 14.4.5 SWOT Analysis
  • 14.5 Fitbit, Inc. (Google LLC)
    • 14.5.1 Company Overview
    • 14.5.2 Financial Analysis
    • 14.5.3 Segmental and Regional Analysis
    • 14.5.4 Research & Development Expenses
    • 14.5.5 Recent strategies and developments:
      • 14.5.5.1 Partnerships, Collaborations, and Agreements:
      • 14.5.5.2 Product Launches and Product Expansions:
  • 14.6 HealthifyMe Wellness Private Limited
    • 14.6.1 Company Overview
    • 14.6.2 Recent strategies and developments:
      • 14.6.2.1 Product Launches and Product Expansions:
  • 14.7 PlateJoy LLC
    • 14.7.1 Company Overview
  • 14.8 Tempus AI, Inc.
    • 14.8.1 Company Overview
    • 14.8.2 Financial Analysis
    • 14.8.3 Research & Development Expenses
    • 14.8.4 Recent strategies and developments:
      • 14.8.4.1 Product Launches and Product Expansions:
      • 14.8.4.2 Acquisition and Mergers:
    • 14.8.5 SWOT Analysis
  • 14.9 Welldoc, Inc.
    • 14.9.1 Company Overview
    • 14.9.2 Recent strategies and developments:
      • 14.9.2.1 Partnerships, Collaborations, and Agreements:
  • 14.10. Sidekick Health ehf
    • 14.10.1 Company Overview
    • 14.10.2 Recent strategies and developments:
      • 14.10.2.1 Partnerships, Collaborations, and Agreements:
      • 14.10.2.2 Acquisition and Mergers:

Chapter 15. Winning Imperatives of Digital Health For Obesity Market

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦